The FDA has even accredited a drug built with cannabidiol for that reason (Epidiolex). But the agency only endorses it for 2 scarce varieties of childhood epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome. Analysis will go on to examine potential therapeutic effects of cannabis to aid